Search results
Results from the WOW.Com Content Network
The name "Ritalin" derives from Marguerite "Rita" Panizzon, the wife of Leandro Panizzon, who first synthesized the drug in 1944. Rita was the first person to take methylphenidate, and described its effects to her husband.
There is public backlash against treating ADHD with stimulant medication, especially Ritalin. 1978: For decades, a positive response to stimulant medication was considered evidence that a child had a mental disorder.
The FDA approved the psychostimulant methylphenidate (Ritalin) in 1955. It became more popular as an ADHD treatment as the disorder became better understood and diagnoses increased.
The compound was first synthesized in 1944 by Leandro Panizzon and marketed as “Ritalin” by Ciba-Geigy Pharmaceutical Company in 1954 (Morton and Stockton 2000; Rothenberger and Neumärker 2005). The name “Ritalin” derives from the first name of Panizzon’s wife, i.e. Marguerite or “Rita” (Rothenberger and Neumärker 2005).
The history of ADHD goes back over a hundred years. Learn more about how ADHD has come about and the historical timeline of medications such as Ritalin and Adderall.
Introduction of Ritalin. Today, methylphenidate is the stimulant doctors most often prescribe for children with ADHD. It was first made in 1944, and marketed in 1954 as Ritalin.
When did the FDA approve Ritalin? Methylphenidate was first approved by the U.S. Food and Drug Administration in 1955 for treating what was then referred to as hyperactivity.
It came on the market in 1954 under the now-familiar brand name Ritalin. Methylphenidate was created by a chemist, Leandro Panizzon, in Switzerland. He is said to have tested it on his wife, Marguerite, whose nickname was Rita.
In 1961, Ritalin was approved for treatment of “behavior problems” in children.
Although it acts as a stimulant in most people, Ritalin calms and focuses people with ADHD. Ritalin’s mode of action is unknown, but researchers speculate that the drug reduces the symptoms of ADHD by increasing the amount and activity of a neurotransmitter in the brain.